Close

Merck To Present Innovative Products for Displays at the FPD International in Makuhari (Japan)

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Merck KGaA announced today that it will be exhibiting at the FPD International, one of the leading events for the flat panel display industry, from November 10 to 12, 2010 in Makuhari / Chiba, (Japan). The global pharmaceutical and chemical company will be highlighting its innovative products for the display, lighting and photovoltaics segments.

Within its liquid crystal product range, Merck is going to present PS-VA (PS-VA = Polymer-Stabilized-Vertical-Alignment), a novel premium technology that offers better contrast, greater brightness, faster switching speed and makes it possible to reduce power consumption in LCD televisions. The colors appear more intense, warmer, and more natural. In addition, the spatial depth of the display is greater and movements are more lively. Also the newest screen-generation – 3D displays – will profit from this Merck technology. Merck’s PS-VA materials are a part of the innovative licristal® portfolio, which is based on a combination of a liquid crystals mixture with specially designed reactive mesogens resulting from a sophisticated production process.

Merck will also be providing information on its liquid crystal materials for ultra-fast switchable Blue Phase devices, which is seen as a future technology for extremely rapid picture motion, high contrast ratio and wide viewing angle. Cost-effective production is predicted due to the cell layout without alignment layers and less critical cell gap control.

 

 

Latest stories

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back